Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures.
Vander Velde R, Yoon N, Marusyk V, Durmaz A, Dhawan A, Miroshnychenko D, Lozano-Peral D, Desai B, Balynska O, Poleszhuk J, Kenian L, Teng M, Abazeed M, Mian O, Tan AC, Haura E, Scott J, Marusyk A. Vander Velde R, et al. Among authors: durmaz a. Nat Commun. 2020 May 14;11(1):2393. doi: 10.1038/s41467-020-16212-w. Nat Commun. 2020. PMID: 32409712 Free PMC article.
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, Kubota Y, Ogbue OD, Zawit M, Madanat Y, Bat T, Balasubramanian SK, Awada H, Ahmed R, Mori M, Meggendorfer M, Haferlach T, Visconte V, Maciejewski JP. Bahaj W, et al. Among authors: durmaz a. J Hematol Oncol. 2023 Aug 3;16(1):91. doi: 10.1186/s13045-023-01480-y. J Hematol Oncol. 2023. PMID: 37537667 Free PMC article.
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
Attardi E, Savi A, Borsellino B, Piciocchi A, Cipriani M, Ottone T, Fabiani E, Divona M, Travaglini S, Pascale MR, Awada H, Durmaz A, Visconte V, Della Porta MG, Venditti A, Maciejewski JP, Gurnari C, Voso MT. Attardi E, et al. Among authors: durmaz a. Blood Adv. 2023 Sep 12;7(17):5122-5131. doi: 10.1182/bloodadvances.2023010173. Blood Adv. 2023. PMID: 37327116 Free PMC article.
Measuring competitive exclusion in non-small cell lung cancer.
Farrokhian N, Maltas J, Dinh M, Durmaz A, Ellsworth P, Hitomi M, McClure E, Marusyk A, Kaznatcheev A, Scott JG. Farrokhian N, et al. Among authors: durmaz a. Sci Adv. 2022 Jul;8(26):eabm7212. doi: 10.1126/sciadv.abm7212. Epub 2022 Jul 1. Sci Adv. 2022. PMID: 35776787 Free PMC article.
Molecular patterns identify distinct subclasses of myeloid neoplasia.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, Ogbue OD, Ahmed R, Pagliuca S, Awada H, Kubota Y, Mori M, Ponvilawan B, Al-Share B, Patel BJ, Carraway HE, Scott J, Balasubramanian SK, Bat T, Madanat Y, Sekeres MA, Haferlach T, Visconte V, Maciejewski JP. Kewan T, et al. Among authors: durmaz a. Nat Commun. 2023 May 30;14(1):3136. doi: 10.1038/s41467-023-38515-4. Nat Commun. 2023. PMID: 37253784 Free PMC article.
197 results